Introduction
One of the fundamental parameters determining synaptic strength is the release probability of the presynaptic bouton. Release probability is classically assessed in electrophysiological recordings from the postsynaptic neuron. In the neocortex and hippocampus, however, two neurons are frequently connected by more than one synapse, which makes it very difficult to achieve a situation in which responses from a single synapse can be electrophysiologically isolated. Furthermore, both presynaptic changes (vesicle depletion and changes in release probability) and changes on the level of postsynaptic receptors (e.g., phosphorylation, desensitization, saturation, lateral diffusion, and internalization) contribute to the variability of postsynaptic responses 1, 2 . These effects become even more difficult to disentangle during high-frequency stimulation, when all physiological parameters change simultaneously as the synapse struggles to maintain transmission. Owing to these complications, it is an attractive proposition to assess synaptic physiology with functional imaging methods, as they convincingly isolate responses from a single synapse even if other synapses on the same neuron are active at the same time. Whereas a large number of imaging studies used postsynaptic Ca 2+ transients as a readout of synaptic efficacy, it is now possible to intercept synaptic transmission at the level of cleft glutamate, effectively isolating presynaptic dynamics from postsynaptic changes.
Overview of optical glutamate sensors
In the past decade, two types of optical glutamate sensors have been developed: chemically labeled sensors and GEGIs. Both types of sensors utilize a glutamate-binding protein that is either labeled with a synthetic fluorophore or fused to a fluorescent protein. Sensors based on the ligand-binding domain of an AMPA receptor (AMPAR) subunit conjugated with a small fluorescent dye molecule near the glutamate-binding pocket have been used to image bulk extrasynaptic glutamate dynamics in the brain 3, 4 . A chemical Förster resonance energy transfer (FRET)-based approach, combining a donor and acceptor fluorophore with the glutamate-binding protein iGluR5-S1S2 (Snifit-iGluR5) 5 showed an improved fluorescence change in cultured cells but has not yet been applied to brain tissue.
Sparse and cell-specific labeling without background fluorescence, a precondition for single-synapse studies, seems to be difficult to achieve with chemically labeled sensors.
The first fully GEGI, called FLIPE 6 , was FRET-based and contained a glutamate-binding protein (GltI from Escherichia coli) located between an N-terminal enhanced CFP (ECFP) and a C-terminal YFP called Venus. Later improved to reach a maximum CFP/YFP ratio change of 44% and a dissociation constant (K d ) of 2.5 µM 7, 8 , the sensor SuperGluSnFR allowed measurements of the time course of synaptic glutamate release and spillover in hippocampal cultures. However, the signal-tonoise ratio (SNR) of SuperGluSnFR was still low, and~30 traces had to be averaged to measure glutamate release in response to single action potentials (APs). A substantial improvement was the development of iGluSnFR 9 . iGluSnFR is an intensity-based glutamate sensor constructed from E. coli GltI and circularly permuted enhanced GFP. Its high fluorescence dynamic range (ΔF/F max of 4.5) and K d of~4 µM make it a very suitable tool for investigating cleft glutamate dynamics. iGluSnFR has been used to measure glutamate in a variety of tissues, such as the retina 10 , visual cortex 11 , and olfactory bulb 12 . We and others developed variants displaying different kinetics, affinities, and emission profiles [13] [14] [15] . Those new GEGIs with varied biophysical properties enable researchers to select the most appropriate sensor depending on the biological question (bulk tissue versus single synapse) and imaging system (camera, galvanometric laser scanner, or resonant scanner).
Comparison with other methods to image presynaptic function
To image presynaptic function, fluorescent glutamate sensors are not the only possibility. The change in vesicular pH during vesicle exocytosis and recycling/reacidification has been successfully exploited to measure the activity of individual presynaptic terminals. SynaptopHIuorin, the first genetically encoded pH indicator, was based on a pH-sensitive GFP variant fused to the C terminus of synaptobrevin/VAMP2 to target the sensor to the inner surface of synaptic vesicles 16 . Other vesiculartargeting strategies used fusion to synaptophysin 17 , synaptotagmin 18 , and the vesicular glutamate transporter VGLUT 19 . Spectrally red-shifted sensors with a red fluorescent pH-sensitive protein such as VGLUT-mOrange2 (ref. 20 ) and sypHTomato 21 were developed, and the ratiometric sensor RatiosypHy 22 was instrumental in showing the arrested development of synapses in dissociated neuronal culture. In addition, in primary cultures, pHluorins are sufficiently sensitive to detect single-vesicle release events [23] [24] [25] . It is even possible to localize individual fusion events with a precision exceeding the resolution limit of the microscope 26 . Analysis of release during high-frequency activity, however, is difficult with pH-based methods: reuptake and reacidification are slow processes, leading to rapid accumulation of green fluorescence inside active synaptic terminals. Furthermore, pH-based indicators provide no information about the glutamate content (filling state) of individual vesicles. Another technique for studying presynaptic function is to image the loading and unloading of amphiphilic styryl dyes (FM dyes), initially developed to study vesicle recycling at the neuromuscular junction 27 . The lack of cellular selectivity prevents the use of FM dyes at individual synapses in the densely packed neuropil. In addition, the relatively long partitioning time of FM dyes in and out of the membrane (seconds) renders the relation between staining/destaining events and sub-millisecond glutamate release rather obscure.
Overview of the procedure
The Procedure can be divided into two sections (Fig. 1) ; sensor development (Steps 1-44) and functional imaging of synaptic activity in hippocampal slice cultures (Steps 45-62).
Sensor development (Steps 1-44)
Although iGluSnFR is an excellent general-purpose GEGI, it may be necessary to further optimize specific properties, such as affinity for glutamate (K d ), brightness, or kinetics, for specific experiments. Optimization starts with structure-guided mutations of residues close to the glutamate-binding pocket ( Fig. 1a) ( Step 1). Newly generated variants are expressed in E. coli, purified, and tested in vitro for glutamate-induced changes in fluorescence (Steps [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . If the dynamic range is deemed sufficient, affinity and kinetics are determined by stopped-flow fluorimetry (Steps 21-37). The most promising candidates are expressed and characterized in HEK cells and, finally, in neurons (Steps 43-62). We found considerable differences in the absolute affinity and kinetics of sensor molecules in solution, as compared to those of the same molecules tethered to the plasma membrane of cells 13 . Relative differences between GEGIs, however, were conserved, validating the use of in vitro calibrations for sensor optimization.
Imaging synaptic function (Steps 43-62)
Single-cell electroporation is the method of choice to achieve very sparse expression of glutamate sensors in organotypic culture of brain tissue (Fig. 1b) (Steps 46-56). The sparse expression makes it easy to follow the axon of a patch-clamped sensor-expressing neuron to a distal projection area, e.g., cornu ammonis 1 (CA1). Although camera-based systems are ideal for functional imaging in dissociated neuronal culture, two-photon microscopy is typically used to detect weak functional signals deep in scattering tissue (Steps 57-62). The optimal strategy for functional imaging depends on the goal of the experiment: to obtain spatial information about the fusion sites of vesicles on individual presynaptic boutons, we use fast frame scans and slower GEGIs (iGluSnFR) (Step 62A). To accurately determine the amplitude of individual glutamate transients, a prerequisite for optical quantal analysis, spiral scans on individual boutons provide increased temporal resolution and better SNR (Step 62B). Although 500 Hz provides sufficient temporal resolution for iGluSnFR imaging, we increase the spiral scan frequency to 1 kHz for ultrafast GEGIs.
Limitations of the method
Glutamate diffuses out of the synaptic cleft in <1 ms. Even the fastest GEGIs cannot monitor the true kinetics of free glutamate diffusion because the sensor needs time to rearrange its conformation to become fluorescent. In addition, scanning microscopy has limited temporal resolution. For capturing sub-millisecond fluorescence changes, it would be necessary to park the excitation beam on the synaptic cleft. This is not a technical problem, but in practice, point-scan experiments are extremely sensitive to small lateral movements of the active bouton in the tissue. At the moment, galvanometric scanning can still adequately sample the fastest GEGIs.
The number of trials that can be obtained from a single bouton is limited by the unavoidable bleaching of the indicator molecules and eventual destruction of the release machinery by toxic photoproducts (e.g., oxygen radicals). Therefore, the laser exposition per single AP should be reduced to a minimum. To measure GEGI transients in response to individual APs, we image in spiral mode for~80 ms. We routinely acquire~100 trials from single boutons without any decay in amplitude or release probability (see the 'Experimental design' section and Supplementary Fig. 1c ). By using lower laser power, this number can be extended to 200 trials at the cost of a slightly lower SNR. Longer intervals between trials allow replenishing indicator molecules by lateral diffusion, Plasmid preparation
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Experimental design
Development and characterization of fast glutamate probes Site-directed mutagenesis and protein expression/purification are done by following standard procedures and should lead to high yields of the GEGIs, with a purity >90% in a single-step purification process (determined by SDS-PAGE). One of the most important parameters is the fluorescence dynamic range ((F +glu -F −glu )/F −glu ), which is a measure of the fluorescence change upon glutamate binding. If the dynamic range of the new GEGI variant is <2, the probe's response to glutamate is not high enough to be suitable for cellular experiments. The affinity of the GEGI, expressed as K d , must be appropriate for the expected glutamate concentration in the cellular or tissue environment. If the goal of the experiment is to distinguish synaptic failures (no glutamate release and no GEGI signal) from successes (stimulation-induced glutamate release), a very high affinity is desirable. If a linear response is important, e.g., to estimate the number of vesicles released simultaneously, a slightly lower affinity might be advantageous. For a GEGI to be a useful probe for in vivo imaging, it also needs to be specific for glutamate. Therefore, binding to other ligands must be assessed (Fig. 2a) . As iGluSnFR is based on the glutamate/aspartate ABC transporter protein (Gltl), it is expected that the sensor will retain a substantial affinity for aspartate. However, it should be unresponsive to serine or glutamine. Most of the GEGIs indeed show a fluorescence response to aspartate binding, sometimes even with a higher fluorescence dynamic range than that for glutamate. However, the affinity is often lower, and, fortunately, aspartate does not act as a neurotransmitter. Nevertheless, aspartate sensitivity must be considered when monitoring glutamate in non-neuronal tissues or cellular compartments.
To observe fast events, such as neurotransmission in synapses, the kinetics of the formation and decay of the fluorescence state are critical. Thus, the association and dissociation of the purified GEGIs are determined in vitro by stopped-flow fluorimetry (Fig. 2b) . While performing association measurements, it is essential to record baselines for the buffer to obtain the zero level of the photomultiplier tube (PMT) and for obtaining the starting point of the fluorescence increase of the glutamate-free GEGI. This recording is essential to detecting rapid phases (>1,000/s) that are faster than the resolution of the stopped-flow device (~1-ms mixing time) and thus appear as jumps. Recording the dissociation of glutamate from the GEGIs is especially challenging, as the glutamate must be removed from the sensor, which is difficult due to lack of chemical traps. We circumvent this obstacle by mixing the glutamate-bound GEGI with the high-affinity GluBP 600n (K d~6 00 nM) 6 . However, for low-affinity variants, these measurements are limited by the concentration of GluBP 600n available and by the very small decrease in fluorescence amplitude. Low-affinity GEGIs (K d >1 mM) must be saturated with glutamate concentrations in the millimolar range; however, GluBP 600n is at best concentrated to be~1 mM in the optical cell. As only a small fraction of the GEGI is dispossessed of its glutamate, only a very small decrease in fluorescence occurs and, thus a small signal is observed.
For in vivo use of the GEGIs, the sensors must be attached to the outer membrane of a cell. Thus, the sensors are cloned in mammalian expression vectors, which add a mouse Ig κ-chain for secretion and a platelet-derived growth factor receptor (PDGFR) transmembrane helix for membrane attachment. To confirm correct localization, the sensor is expressed in cell lines (HEK293T cells) and titrated with glutamate to determine the cellular K d . We found that the attachment to the outer membrane of the cell increases the variants' affinity for glutamate by a factor of up to 20-fold. Relative differences between the variants, however, are conserved 13 . This affinity increase must be considered when choosing a suitable sensor for in vivo applications.
Imaging synaptic glutamate release with two-photon microscopy For expression in neurons, we clone the GEGIs behind the human synapsin 1 promoter and electroporate single neurons in organotypic slice cultures of rat hippocampus. GEGIs are relatively dim in the absence of glutamate, making it difficult to focus on small structures such as axonal boutons. We routinely use co-expression of a bright RFP (tdimer2 or tdTomato) to label the cytoplasm and follow the axon through the tissue; the newly developed CyRFP1 (ref. 28 ) is also an excellent choice for this purpose. The red fluorescence also provides additional information about the volume of individual boutons. Electroporated CA3 neurons are clearly visible under a stereomicroscope (5× objective, DsRed filter set) 2-4 d after electroporation (Fig. 3a,b) . Two-photon excitation at 980 nm reveals membrane localization of the GEGI (Fig. 3d) as well as axons and boutons of the expressing neurons in CA1 stratum radiatum, far away from the somata in CA3 (Fig. 3c) . Targeted patch-clamp recording from a transfected neuron allows triggering of single APs by brief depolarizing current injections (Fig. 3e) . Simultaneous imaging of a single bouton (spiral scan path at high zoom reveals green fluorescence transients time-locked to the APs, indicating glutamate release from the stimulated bouton. In spite of reliable AP generation, synapses frequently failed to release glutamate (Fig. 3e , gray traces), indicating a stochastic vesicle fusion process.
Fusion site localization
Although spiral scans are optimal for determining the peak amplitude of the glutamate signal, we use fast frame scans (16 × 16 pixels, frame rate = 62.5 Hz) to localize the probable location of the fusing Setup for affinity and selectivity determination. GEGI in assay buffer is placed into a fluorescence cuvette with a magnetic stirrer and placed inside the sample chamber of the fluorescence spectrometer. With an Aladdin pump, the ligand (Glu, Asp, and Ser) is continuously added to the cuvette while the fluorescence is recorded (λ ex = 492 nm, λ ex = 514 nm). (Right) Examples of affinity curves of a GEGI for glutamate (black squares) and aspartate (black circles). The fluorescence emission is corrected for dilution and bleaching and plotted against the glutamate concentration in the chamber. The data are then fitted with a Hill equation (green and orange traces for glutamate and aspartate, respectively). b, (Left) Setup for stopped-flow kinetic measurement. The solutions are rapidly mixed in the mixing chamber and then pushed into the optical cell, where the fluorescence is excited at 492 nm and emission is detected by a photomultiplier tube with a cutoff filter (>530 nm). For association, the GEGI in assay buffer without glutamate is loaded into drive syringe B and mixed with assay buffer containing increasing concentrations of glutamate loaded into drive syringe A. For dissociation, the GEGI in assay buffer with saturating glutamate concentration is loaded into drive syringe B and mixed with GluBP 600n in assay buffer loaded into drive syringe A. For both measurements, the PMT zero level is determined by mixing identical solutions (assay buffer with assay buffer), and the intrinsic fluorescence of the GEGI is recorded by mixing the GEGI in assay buffer with assay buffer (both without Glu). vesicle in individual trials. The spatial peak of the averaged signal does not necessarily occur in the center of the bouton (Fig. 4a) , but is often close to the edge (Fig. 4b) , reflecting the random orientation of the synaptic cleft on the surface of the bouton. To localize individual fusion events in noisy images, we fit a 2D Gaussian kernel (Fig. 4c) to the first frame after stimulation. Plotting the center positions of Gaussian fits (Fig. 4c) relative to the morphological outline of the bouton (red channel) showed a small region of release, the active zone (Fig. 4d) . Increasing the extracellular Ca 2+ concentration from 1 to 4 mM did increase the amplitude of single-trial responses, but not the size of the apparent active zone (Fig. 4e) . The higher cleft glutamate concentrations caused by single APs in 4 mM Ca 2+ suggest the simultaneous release of multiple vesicles or a switch from partial to full release. No clustering was found when we fitted green fluorescence before stimulation or in trials classified as failures (Fig. 4f,g ).
Spiral scans and amplitude extraction
As we do not know a priori where on the bouton the highly localized and short-lived GEGI signals will appear (Fig. 5a ), we must sample the entire surface of the bouton as quickly as possible. Traditional raster scanning (Fig. 5b ) requires extreme acceleration of the scanning mirror at the end of each scan line, limiting the maximum frame rate to~120 Hz. By scanning in a spiral pattern, we are able to sample the same area at frequencies of up to 1 kHz. The point-spread function (PSF) of our two-photon microscope is 0.5 µm in the imaging plane and 1.7 µm along the optical axis (full width at half maximum (FWHM), measured with 170-nm fluorescent beads). As the PSF elongates in the axial direction, we sample the upper and lower surface of the bouton simultaneously. Our goal is to extract the amplitude of fluorescent transients from spiral scans independent of the exact position Images were acquired at 500 Hz at 34°C. Individual trials are classified as successes if the peak amplitude of the GEGI transient is >2σ (green traces) and as failures when the peak amplitude is <2σ (gray traces). Note the propagation delay between presynaptic APs and glutamate release events at the distal bouton. DG, dentate gyrus; NA, numerical aperture; Syn1, synapsin 1.terminal. c,e reproduced with permission from Helassa et al. 13 , National Academy of Sciences.
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of the fusion site on the bouton. To do so, the unfolded spiral scans are plotted as straight lines underneath each other, resulting in a space-time plot (Fig. 5c) . Typically, the spiral scan intersects the diffusing cloud of glutamate two or three times per scan, resulting in multiple 'hot spots' that all contain information about the same release event. To extract amplitude information, columns (corresponding to positions on the bouton) are sorted according to the change in fluorescence (Fig. 5d ). The columns with the largest signal (ΔF > ΔF max /2) are averaged (ROI). In trials in which no fluorescence change is detected (failures), the same columns as in the last 'success' trial are analyzed. As opposed to a static ROI, this analysis procedure is robust against minute drift of the tissue between trials and does not require a priori knowledge of the fusion location. We extract the amplitude from the resulting fluorescence trace by fitting a single exponential function to the decay of the fluorescence transient. To estimate the noise level (photon shot noise) in each experiment, we perform the same fitting procedure to a section of the baseline (before stimulation). As expected, the baseline amplitudes are close to zero ( Fig. 5f , gray dots and columns). Typically, the histogram of all responses (green) also shows one cluster around zero (failures of release); the remaining responses (successes) form an asymmetric, broad peak between 40 and 160% ΔF/F 0 . A close inspection of the spatial distribution of the signal (Fig. 5e , average of ten successes) shows a rapid decay of the peak, but no lateral spread, as might be expected from a diffusion process. It is important to note that the ] o . a, Morphology of individual boutons. Red fluorescence was upsampled (16 × 16 pixels to 128 × 128 pixels), aligned, and averaged over all trials. b, Average response of iGluSnFR superimposed with bouton outline (black line) from the red channel (morphology). The bouton outline was generated by thresholding the red channel, followed by smoothing. c, 2D Gaussian fit to average response. On average, the full width at half maximum (FWHM) was 763 ± 29 nm (n = 12; five boutons shown here). d, Plotting the center position of 2D Gaussian fits to individual trials. Fusion appears to be localized to a small region on the bouton (active zone). Amplitude (ΔF/F 0 ) of individual trials is color-coded. e, Increasing the extracellular Ca 2+ concentration increased the amplitude of individual responses, but did not lead to release events outside the active zone. f, Fitting responses classified as failures (<2σ of baseline noise) did not reveal any clustering, indicating that there was indeed no localized signal in these trials (true negatives). g, Fitting frames before stimulation (green baseline fluorescence) also did not result in clustering. Scale bars, 0.5 µm. Av., average. diffusion of free glutamate out of the synaptic cleft happens in <1 ms and cannot be resolved by iGluSnFR or another GEGI. Instead, what we observe is the relatively slow unbinding of glutamate from quasi-stationary iGluSnFR molecules, explaining the lack of lateral spread of the signal. • pET41a(+) (bacterial expression vector used to express GEGI variants in E. Protein expression and purification • Pierce protease inhibitor tablets (EDTA-free; Thermo Fisher Scientific, cat. no. A32965) ! CAUTION Pierce protease inhibitor tablets are dangerous and cause severe skin burns and eye damage. Wear protective gloves, clothing, and eye protection. Wash your hands thoroughly after handling them.
Materials Biological materials
• HisTrap high-performance column (GE Healthcare, cat. no. 17524801) c CRITICAL EDTA-free inhibitor is critical to ensuring binding of the His-tagged protein to the HisTrap high-performance column.
• SnakeSkin dialysis tubing (3 Elution buffer for protein purification Elution buffer is 50 mM HEPES-Na + , 200 mM NaCl, and 500 mM imidazole, pH 7.5, filtered (0.2-µm pore size). Stored at 4°C for up to 2 weeks.
Storage buffer for protein purification
Storage buffer is 50 mM HEPES-Na + , 100 mM NaCl, pH 7.5; store at 4°C for up to 2 weeks.
Assay buffer for biophysical characterization
Assay buffer is 50 mM HEPES-Na + , 100 mM NaCl, and 2 mM MgCl 2 , pH 7.5; store at 4°C for up to 2 weeks.
Association buffers for biophysical characterization • 1 µM GEGI in assay buffer; store at 4°C for up to 1 d.
• 0.1-10× K d L-Glutamic acid in assay buffer; store at 4°C for up to 1 d. c CRITICAL To measure the full range of response in dependence of the glutamate concentration, the glutamate concentration mixed with the GEGI must be distributed around the K d .
Dissociation buffers for biophysical characterization • 2 mM GluBP 600n in assay buffer; store at 4°C for up to 1 d.
• 1 µM GEGI in assay buffer; store at 4°C for up to 1 d.
• 1 µM GEGI in assay buffer with saturating glutamate (10× K d ); store at 4°C for up to 1 d.
Complete DMEM
Complete DMEM is DMEM, 1× NEAA, 10% (vol/vol) FBS, and 100 U/mL penicillin-streptomycin; store at 4°C for up to 2 months.
HEK293T cell imaging buffer HEK293T cell imaging buffer is 20 mM HEPES-Na + , 145 mM NaCl, 10 mM glucose, 5 mM KCl, 1 mM MgCl 2 , and 1 mM NaH 2 PO 4 , pH 7.4; store at 4°C for up to 6 months.
Slice culture medium
Slice culture medium is 394 mL of MEM, 20% (vol/vol) heat-inactivated horse serum, 1 mM L-glutamine, 0.01 mg/mL insulin, 14.5 mM NaCl, 2 mM MgSO 4, 1.44 mM CaCl 2 , 0.00125% ascorbic
Slice culture transduction solution
Slice culture transduction solution is 10 mM HEPES, 145 mM NaCl, 25 mM D-glucose, 2.5 mM KCl, 1 mM MgCl 2 , and 2 mM CaCl 2 . Measure the pH using a pH meter and adjust the pH to 7.4 by adding NaOH or HCl. Measure the osmolality with a micro-osmometer and ensure that the osmolality is between 310 and 320 mOsm/kg. If the osmolality is out of range, a mistake was made during solution preparation. The solution must be sterile-filtered (0.2-µm pore size); store at 4°C for up to 6 months and pre-warm the solution to 37°C before use.
Artificial cerebrospinal fluid (ACSF) for neuronal imaging ACSF is 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 127 mM NaCl, 25 mM D-glucose, 2.5 mM KCl, 2 mM CaCl 2 , and 1 mM MgCl 2 , pH adjusted to 7.4. ACSF must be saturated with 95% O 2 and 5% CO 2 . Osmolality should be between 310 and 320 mOsm/kg. Store for a maximum of 1 week at 4°C. Bubble with carbogen (95% O 2 , 5% CO 2 ) during warm up to prevent Ca 2+ precipitation. Maintain the perfusion reservoir at 34°C to prevent bubble formation in the recording chamber.
K-gluconate-based intracellular solution K-gluconate-based intracellular solution is 10 mM HEPES, 135 mM K-gluconate, 0.2 mM EGTA, 4 mM MgCl 2 , 4 mM Na 2 -ATP, 0.4 mM Na-GTP, 10 mM Na 2 -phosphocreatine, and 3 mM L-ascorbic acid, pH adjusted to 7.2 with KOH. Osmolality should be between 290 and 300 mOsm/kg. The solution must be sterile-filtered (0.2-µm pore size). Store at −20°C for a maximum of 12 months. Aliquots in Eppendorf tubes can be stored at −80°C for a maximum of 6 months. Store on ice during the experiment to slow ATP hydrolysis.
Equipment setup

Equipment for functional imaging in tissue
We built a two-photon microscope based on an Olympus BX51WI microscope with a pE-4000 LED light source for epifluorescence and IR Dodt contrast. A Ti:sapphire laser system with dispersion compensation was coupled in through an EOM, a 3× telescope, 5-mm scan mirrors, a compound scan lens (f = 50 mm 33 ), a dual-camera port with an IR mirror, and a water immersion objective. Red and green fluorescence was detected through the objective and the oil-immersion condenser using two pairs of photomultiplier tubes. 560 DXCR dichroic mirrors and 525/50 and 607/70 emission filters were used to separate green and red fluorescence. Excitation light was blocked by short-pass filters. During epifluorescence illumination, substage PMTs were protected by an NS45B shutter. For electrical stimulation of individual neurons, we mounted the headstage of a MultiClamp 700B amplifier on an MP-285 micromanipulator on a motorized stage that also moved the perfusion chamber (quartz glass bottom). Temperature was controlled by Peltier heating of the oil-immersion condenser and in-line heating of the ACSF. The setup was controlled by MATLAB software (ScanImage 31 and Ephus 32 ) via data acquisition boards. At the start of a trial, electrophysiology and image acquisition were synchronized by a hardware trigger (transistor-transistor logic (TTL) pulse). During a trial (2 s, typically), laser power was regulated via an EOM and restricted to the periods of expected glutamate release (20-to 80-ms window, depending on GEGI kinetics) to minimize bleaching. c CRITICAL To minimize bleaching by excessive excitation, the microscope must be designed to detect emitted photons very efficiently. Using only the objective for fluorescence detection is not sufficient to achieve single-vesicle sensitivity. Condenser detection (oil immersion, 1.4 NA, large field of view) is essential to the success of single-synapse experiments with many trials. Replace aging PMTs that show excessive dark counts.
c CRITICAL The oil-immersion condenser must be permanently heated (day and night) if a recording temperature above room temperature (20°C) is desired. This can be achieved with flexible heating pads or Peltier elements. As the thermal mass of the condenser is very large, constant-current heating is sufficient, provided that the temperature of the ACSF is additionally regulated by a feedback control circuit (in-line heater). A climate chamber would be an attractive solution but is not compatible with direct-mounted PMTs.
c CRITICAL If a galvanometric scanning system is used, the microscope software must support arbitrary line scans or spiral scans 34 . The code for arbitrary line scans that we developed for our original study is now incorporated into the ScanImage software (v.2016 and later). ScanImage is developed and supported by Vidrio
Technologies as an open-source research resource. A resonant scanning system may be sufficiently fast in frame mode if extreme zoom-in (few scan lines) can be realized.
Procedure
Generation of GEGIs • Timing 1 week;5-h hands-on time c CRITICAL We have made a number of GEGI-encoding plasmids available via Addgene (see the Reagents section). Follow Steps 1-42 in order to design GEGIs with tailored biophysical parameters. 1 Analyze protein 3D structures of the 99% homolog of GltI of Shigella flexneri (PDB 2VHA) and the literature 35, 36 to assign critical residues involved in glutamate binding. Substitute essential residues with amino acids with similar physical properties. Avoid radical changes in amino acid size or charge, as this will frequently result in misfolded or otherwise nonfunctional proteins. 2 Subclone the iGluSnFR gene from a mammalian expression vector into a bacterial expression vector (pET41a) using restriction digestion of BglII and NotI and ligation (T4 DNA ligase), following the manufacturer's protocol. ! CAUTION Subcloning requires DNA to be analyzed by agarose gels. This requires the use of DNAintercalating fluorescent dyes (e.g., ethidium bromide or Sybr green) that are highly toxic mutagens and should be handled with care. DNA imaging systems are based on UV lamps, so appropriate personal protective equipment should be used. 3 Insert point mutations using the QuikChange XL Site-Directed Mutagenesis Kit and following the manufacturer's instructions; confirm new variants by DNA sequencing. 4 Subclone the glti gene encoding GluBP 600n from pRSET FLIPE 600n (ECFP-ybeJ-Venus) into pET30b (His-fusion expression vector) at the BglII and NotI restriction sites.
Expression and purification of new GEGIs • Timing 3 d; 10-h hands-on time
5 Transform 1 μL of iGluSnFR variants or GluBP 600n plasmid DNA into 50 μL of E. coli BL21 (DE3) gold chemically competent cells. 6 Pick one colony and grow it overnight in 10 mL of LB medium supplemented with 100 µg/mL kanamycin at 37°C on an orbital shaker set to 180 r.p.m. (pre-culture). 7 Inoculate 1 L of LB medium containing 100 µg/mL kanamycin with whole pre-culture and incubate at 37°C on an orbital shaker set to 180 r.p.m. until the OD 600 value reaches 0.6-0.8. 8 Cool the cells to 20°C. 9 Induce protein expression with 0.5 mM IPTG and incubate at 20°C and 180 r.p.m. on an orbital shaker overnight. c CRITICAL STEP Best protein yields are obtained when inducing expression during the exponential phase of growth (OD 600 0.6-0.8), overnight at 18-20°C. 10 Harvest the cells by centrifugation at 3,000g for 15 min at room temperature, resuspend the cells in 40 mL of resuspension buffer supplemented with Pierce protease inhibitor (prepared according to the manufacturer's instructions), and lyse via sonication on ice for 2 min (2 s 'on' and 8 s 'off'). ! CAUTION Wear ear protection equipment during sonication. c CRITICAL STEP Sonication produces heat and may result in the degradation of your protein of interest. Performing sonication on ice and in the presence of protease inhibitors will markedly limit this phenomenon. 11 Remove the cell debris by ultracentrifugation at 100,000g for 45 min at 4°C. c CRITICAL After cell lysis, all steps are performed at 4°C, when possible, to avoid protein digestion by cellular proteases (Steps 12-14) . 12 Load the supernatant on an equilibrated HisTrap high-performance column (nickel affinity resin) mounted on an ÄKTA purification system (flow rate = 4 mL/min) and wash with 40 mL of resuspension buffer. 13 Elute the protein with ten column volumes of a linear gradient of resuspension and elution buffer (0-0.5 M imidazole) and collect in 2-mL fractions. Analyze the purified protein by SDS-PAGE and stain the gel with Coomassie blue. 14 Pool the fractions of interest and dialyze overnight at 4°C in a SnakeSkin Dialysis Tubing (3.5 kDa) against 4 L of storage buffer. c CRITICAL STEP It is essential to perform dialysis to remove the imidazole from your buffer. Otherwise, protein precipitation will occur upon defrosting (from Step 15) . The dialysis MWCO used can be higher than 3.5 kDa, as long as it is <15 kDa.
15 Store purified protein in 1-mL fractions in a -80°C freezer. j PAUSE POINT The purified protein can be stored at -80°C for up to 3 years.
Determination of the dynamic range • Timing 1 h
16 Prepare 50-100 nM iGluSnFR proteins in assay buffer, add to a Hellma microcuvette (50 μL), and place the cuvette into a fluorescence spectrometer pre-equilibrated to 20°C. 17 Record the fluorescence emission spectrum (λ ex = 492 nm and λ em = 497-550 nm) (F -glu ). 18 Add 10 mM glutamate solution to the microcuvette, mix well, and record the fluorescence emission spectrum (λ ex = 492 nm and λ em = 497-550 nm) (F +glu ). 19 To analyze the data, take the maximal emission (~514 nm) of each measurement and calculate the fluorescence dynamic range ((F +glu − F −glu )/F −glu ). 20 Repeat Steps 16-19 twice in order to generate three independent replicates. c CRITICAL STEP If the fluorescence dynamic range is <2, the fluorescence change upon glutamate binding is too low for imaging in hippocampal slices. In that case, try using higher concentrations of glutamate. If the fluorescence dynamic range does not improve, return to Step 1 and select another mutation.
Determination of K d and specificity • Timing 2 h per ligand
21 Prepare 50-100 nM GEGI in 3-mL of assay buffer in a 3,500-µL Hellma quartz cuvette (QS). 
Measurement of kinetics • Timing 5 h; 4 h for association and 1 h for dissociation
c CRITICAL Temperature control is essential for all kinetic measurements. Furthermore, washing the instrument thoroughly after changing the ligand concentration is critical. To correctly analyze the data, baselines and maximum fluorescence intensity lines should be recorded as described below. Always average at least five records ('shots') for each measurement to obtain a representative trace. 28 Association (Steps 28-32) . Mix 1 µM GEGI in assay buffer with the maximal glutamate concentration in assay buffer (10× K d , as determined in Step 27) . Set the fluorescence level after mixing to reach 80% detector saturation by adjusting the gain on the PMT (reference of 1 for normalization).This step will prevent detector overload in future experiments. 29 Mix assay buffer with assay buffer (identical solutions) and record the baseline (reference of 0 for normalization). Note that due to the dark noise of the PMT, the reading may not be zero. 30 Mix 1 µM GEGI in assay buffer with assay buffer. This measurement should result in a straight line and shows the basal fluorescence without a ligand bound. c CRITICAL STEP Steps 28-30 must be performed before starting any association kinetic measurement of a GEGI. This ensures that the instrument is calibrated for maximum/minimum fluorescence detection levels and prevents detector damage. 31 Glutamate-dependent association kinetics. Mix 1 µM iGluSnFR variant in assay buffer with increasing glutamate concentrations in assay buffer (0. Step 27) and take an image of the cells before and after each addition step. c CRITICAL STEP Focus drift may happen when you add glutamate. If that is the case, discard the last data point and move to a different well. 42 Define elliptical ROIs along the cell membrane and determine the fluorescence intensity (ImageJ).
Normalize the intensity for each individual cell and average over a total number of >20 cells. Plot the relative intensity versus glutamate concentration and fit the data with Hill equation (GraphPad Prism v.7).
Cloning in neuronal expression vector • Timing 7 d; 5-h hands-on time
43 Use a QuikChange XL Site-Directed Mutagenesis Kit to insert mutations of promising GEGI variants into the pCI syn iGluSnFR vector and confirm by DNA sequencing. 44 Prepare the plasmid for electroporation using a plasmid DNA preparation kit (e.g., PureLink
HiPure Plasmid Maxiprep Kit).
Culture preparation • Timing 15 min per brain
45 Prepare organotypic slice cultures (rat hippocampus) as described in ref. 30 .
Single-cell electroporation • Timing 10 min plus 10-20 min per slice, depending on slice quality and number of cells to transfect 46 Preparation of plasmids and DNA (Steps 46 and 47). Sterile-filter an aliquot (0.5 mL) of K-gluconate-based intracellular solution through a Millipore Ultrafree centrifugal unit by centrifugation at 16,000g for several seconds in a tabletop centrifuge at 4°C.
47 After removal of the filter insert, add the GEGI plasmids to the desired concentration. Use 40-50 ng/µL for pCI syn iGlu f or pCI syn iGlu u (ref.
13
). For different cell types and GEGIs, the final concentration may have to be determined empirically (range: 1-100 ng/µL). c CRITICAL STEP It is important that the DNA-containing solution is not passed through the Millipore Ultrafree centrifugal filter unit. c CRITICAL STEP To aid visualization of axons and boutons of transfected neurons, mix plasmid encoding for RFP (e.g., tdimer2; 20 ng/µL) with GEGI plasmid to achieve co-expression. j PAUSE POINT The electroporation solution containing the plasmid can be stored between electroporation sessions at -20°C for up to 1 year. 48 Electroporation (Steps 48-56) . Coat silver wire tips and ground electrodes with AgCl by bathing them in a saturated Cl 3 Fe solution for at least 30 min or overnight before first use. 49 Use a micropipette puller (e.g., PC-10) to pull electroporation pipettes. Pull thin-walled borosilicate capillaries to obtain a resistance of 10-15 MΩ when filled with the K-gluconate-based intracellular solution. c CRITICAL STEP Ensure constant pipette resistance for reproducible expression. A too-high pipette resistance leads to low expression, whereas a too-low resistance causes extreme expression levels and toxicity. 50 Backfill an electroporation pipette with~1.2 µL of plasmid mix solution (from Step 47) for each slice to be electroporated. Backfilled pipettes can be kept (in an upright position) for up to 2 h before use. Pipette 1 mL of slice culture transduction solution (37°C) into the microscope chamber.
Transfer one slice culture insert to the chamber (sterile forceps) and add slice culture transduction solution on top of the slice culture for the water immersion objective. Use a sterile 60-mm dish to cover the microscope chamber and transfer it to the microscope to proceed to single-cell electroporation. c CRITICAL STEP To avoid any contamination, place forceps into the hot-bead sterilizer for~10 s before any handling of insert. c CRITICAL STEP Work on an electrophysiology microscope setup in a laminar flow box (see the 'Equipment' section) to prevent contamination. 51 Apply positive pressure to the pipette to approach a cell to electroporate. Monitor the tip resistance of the electroporation pipette by audio output of the Axoporator 800A amplifier throughout the entire procedure. The resistance should be between 10 and 15 MΩ. c CRITICAL STEP Similarly to patch-clamp recording technique, positive pressure on the electroporation pipette is maintained to keep the tip of the pipette clean while penetrating the tissue. c CRITICAL STEP For a reproducible expression level of the plasmids between different electroporation sessions, ensure that the pipette resistance is constant. 52 Move the tip of the electroporation electrode close to a cell of interest while reducing the positive pressure. 53 Approach the cell without sealing the electrode with membranes from other cells in the tissue.
Touch the plasma membrane, which will cause a rise in tip resistance, indicated by a rise in pitch. Immediately release the pressure and wait for the resistance to increase to 25-40 MΩ. Do not apply suction and avoid the formation of a gigaohm seal. 54 Apply a pulse train (e.g., voltage: −12 V, frequency: 50 Hz, pulse width: 500 µs, and train duration: 500 ms). The optimal settings may differ depending on the cell type to be electroporated. c CRITICAL STEP For more reproducible expression levels of the plasmids between different cells, try to wait for the resistance to increase to a similar value before applying the pulse train. 55 Slowly retract the pipette and begin applying very light positive pressure once the pipette is retracted 2-4 µm away from the soma. Increase the positive pressure at more considerable distances from the electroporated cell in order to maintain the cleanliness of the pipette tip. Using the same electrode, repeat Steps 51-55 for each cell to be electroporated. 56 Cover the chamber with a 60-mm dish and transfer it back to the tissue culture hood. Remove all transfection medium and return the insert to the slice culture medium. Typically, 2-4 d are needed for optimal expression levels of GEGIs in hippocampal organotypic slices. However, the optimal time for a cell to express a given plasmid before starting the experiment must be determined empirically 37 .
Stimulation of transfected neurons • Timing 30-90 min per recording, depending on slice quality, the number of cells expressing the electroporated plasmids, and the length of the recording 57 Start a temperature-controlled perfusion system with ACSF and place the organotypic culture in the recording chamber. Weigh down the membrane patch with a c-shaped gold wire. ? TROUBLESHOOTING 58 Tune the Ti:sapphire laser to 980 nm for simultaneous excitation of tdimer2 and GEGI.
? TROUBLESHOOTING 59 Approach a transfected CA3 neuron with the patch pipette, switching between red epifluorescence and IR Dodt contrast (CCD camera).
? TROUBLESHOOTING 60 Establish a gigaohm seal and rupture the membrane patch by brief suction to establish whole-cell configuration. c CRITICAL STEP Stimulate an individual transfected cell to avoid stimulation of presynaptic terminals close to the terminal under scrutiny. This will ensure that the GEGI transients originate from the imaged terminal and are not a consequence of glutamate spillover. 
Troubleshooting
Step 57
Slices are contaminated. See ref. 30 for proper slice culture handling.
Step 58
No cells express the construct. Ensure that the constructs are incorporated into the target cells by adding a fluorescent dye, such as Alexa Fluor 594, to the DNA mix (Step 47). After applying the pulse train to the target neuron (Step 54), take a fluorescence image (e.g., Leica Z6 APO) to ensure that the DNA solution and fluorescent dye were successfully electroporated. For more details for the electroporation procedure, refer to ref. 37 .
Step 59
Cells are dying after transfection with the constructs. Lower the expression of the GEGI, ensure that the pipette resistance (Step 49) is not <10-15 MΩ in the bath before electroporation, and/or reduce expression time. A large pipette tip diameter (low resistance) can lead to overexpression of the GEGI and cell toxicity. Cells should be imaged 2-4 d after electroporation, as longer expression of GEGIs can affect cell health.
Box 1 | Bleaching of GEGI
During imaging, some GEGI molecules bleach, leading to a decrease in baseline fluorescence during each trial ( Supplementary Fig. 1 ). This may cause problems when fitting an exponential function to the decay of the glutamate response, because at least two time constants must be taken into account. To correct individual trials from one bouton for bleaching, fit an exponential decay function to the average of several 'failure' trials. Subtract this function from each trial (failures and successes;
Step 62B(viii)). Between trials, fluorescence partially recovers, indicating lateral diffusion of GEGI molecules within the axonal membrane. Some loss of GEGI fluorescence (20-40%) during the course of the experiment can be tolerated because it does not affect the glutamate-induced relative change in fluorescence (ΔF/F 0 ; Supplementary Fig. 1 ). We found that manual refocusing between trials can lead to substantial bleaching of the indicator. This can be minimized by automated refocusing between trials.
! CAUTION Very strong promoters (cytomegalovirus (CMV)) should not be used for physiological experiments in neurons.
Step 61
The slice is drifting; focus is not stable. Lower the perfusion rate. Check that the temperatures of the ACSF and of the imaging chamber of the microscope are stable to avoid thermal expansion during the experiment.
Step 62A(ii)
The responses are very weak and barely above noise. Wait longer after electroporation for a higher expression level. If the expression levels are too low, the GEGI signal from a single vesicle may be below the detection limit. The detection limit is determined by the noise level of the optical recording setup. Minimize background fluorescence, which can be caused by leaking room light, stray pump laser photons (green), or excessive dark counts in aging PMTs. Condenser detection is sensitive to the refractive index of the immersion oil and correct (Köhler) position.
Step 62A(ix)
The localization seems inaccurate. Calibrate the optical and mechanical performance of your system, using fluorescent microbeads. Imaging of microbeads (0.17-µm diameter) positioned next to a fluorescent presynaptic terminal allows quantification of the accuracy of the response localization procedure.
Step 62A(x)
In cases in which the positions of apparent 'failures' cluster in a second area of the bouton, exclude the bouton from further analysis, as it might be a multi-synapse bouton.
Step 62B(ii)
The success rate in finding a bouton releasing glutamate is very low. This can be due to low release probability. Check the Ca 2+ concentration of the ACSF.
Step 62B(x)
In some trials, the baseline fluorescence may show large fluctuations caused by green fluorescent vesicles passing through the axon. Remove these trials from further analysis. Step 62A(i-x), fusion site localization: 1 h per recording
Timing
Step 62B(i-xi), amplitude extraction and failure analysis: 1 h per recording
Anticipated results
Assessing the properties of neighboring boutons
Once a responding bouton is identified, several neighboring boutons along the same axon can be imaged sequentially. Neighboring boutons frequently have similar release probabilities and response amplitudes (Fig. 6a) . In rare cases, however, we found dramatic differences in response amplitude between neighboring boutons (Fig. 6b) . To test whether boutons on the same axon are functionally similar, we generated random pairs by drawing from our entire set of characterized boutons. The differences between randomly selected boutons are normally distributed (black bars in Fig. 6d ). The actual difference between neighboring boutons ( Fig. 6c ; red line in Fig. 6d ) is at the low end of the distribution, indicating that neighboring boutons tended to have similar release probabilities. A similar result, however nonsignificant, was found when response amplitudes were analyzed (Fig. 6e,f) .
Application of fast GEGIs
Although iGluSnFR has an excellent SNR, it is too slow to resolve vesicle fusion events during highfrequency transmission 39 . The recently developed ultrafast GEGIs iGlu u , and iGlu f 13 resolve individual responses during 100-Hz trains, albeit with slightly lower SNR, as shorter transients correspond to fewer photons collected (Fig. 7a) . For these experiments, scan speed was increased to 1 kHz, and a high Ca 2+ solution was used to increase release probability. Under these conditions, individual (left panels) and their corresponding histogram counts (right panels). b, Glutamate transients (blue dots) and baseline fluorescence (gray dots) of two neighboring boutons located on the same axon measured in ACSF containing 2 mM Ca 2+ and 1 mM Mg 2+ (left panels) and their corresponding histograms (right panels) and their corresponding histogram counts (right panels). c, Synaptic release probability (P r ) (calculated out of~100 trials) of individual boutons (B1) and their neighboring bouton on the same axon (B2); n = 10. The pair of neighboring boutons from a and b are shown in green and blue, respectively. d, Histogram of ΔP r = |P r BX − P r BY|. BX and BY are randomly paired from the dataset in c. The measured difference in Pr, |P r B2 − P r B1| (red vertical line), is significantly smaller than the mean ΔP r of two boutons paired randomly from the same dataset; (P = 0.0148). e, Amplitude of the iGluSnFR signal given a success of a bouton B1 and its neighbor on the same axon (B2); n = 10. The pair of neighboring boutons from a and b are shown in green and blue, respectively. f, Histogram of the difference between the average ΔF/F 0 of successes only of two random boutons. The measured difference of the average ΔF/F 0 of successes from two neighboring boutons (red vertical line) is not significantly different from the mean difference between randomly selected boutons.
boutons typically had a release probability of 1 on the first AP, which rapidly dropped to~0.2 toward the end of the 100-Hz train. After a brief recovery period (0.5 s), most boutons could restore their initial high-release probability (Fig. 7b,c) . Interestingly, the depression also affected the amplitude of individual successes, suggesting a switch from multivesicular release (MVR) to univesicular release during high-frequency activity 1, 40 . Alternatively, a switch from full fusion to partial fusion of synaptic vesicles 41 could explain this observation. Responses from an iGluSnFR-expressing bouton during high-frequency stimulation are shown for comparison (blue traces, Fig. 7a ). Summation of 100-Hz release events drives this slow GEGI toward saturation, making it impossible to disentangle singlepulse responses by deconvolution. As saline with a high calcium concentration (4 mM) was used in these experiments, the prevalence of MVR under more physiological conditions remains to be investigated. In this context, an important advantage of GEGI measurements, as compared with those for genetically encoded Ca 2+ indicators (GECIs) 42 , is their independence from extracellular [Ca 2+ ], allowing investigation of the impact of changes in [Ca 2+ ] e on presynaptic function 43 . In summary, Fig. 7 | Resolving high-frequency transmission with ultrafast GEGI, iGlu u . a, The presynaptic neuron was driven to spike at 100 Hz (ten APs). After a pause of 0.5 s, one more AP was triggered to quantify recovery from depression. iGluSnFR signals (blue) or iGlu u signals (green) were recorded at single Schaffer collateral boutons (only during the 100-Hz train) in the stratum radiatum. Recordings were performed in 4 mM Ca 2+ and 1 mM Mg 2+ to ensure a very high release probability. Note the summation and saturation of iGluSnFR (but not iGlu u ) during the high-frequency train. b, iGlu u responses to the first AP of the 100-Hz train, to the ninth AP of the train, and to the recovery pulse. To minimize bleaching, the bouton was imaged (spiral scans) only during pulses 1, 9, and 11. Note the frequent failures in response to pulse 9. c, Extracted single-trial amplitudes reveal strong depression and full recovery of this bouton. Failures of glutamate release can be seen in response to pulse 9. Note the large amplitude of initial responses compared to depressed responses. Plots were generated with violinplot.m.
ultrafast GEGIs allow direct visualization of short-term plasticity at individual synapses and may help unravel the underlying biophysical mechanisms.
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